ImmuPharma plc (AIM: IMM)
Health Care · Pharmaceuticals · GB
£0.03
+0.92% today · -70.3% 1Y
ImmuPharma plc (AIM: IMM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $27.30M.
Over the last twelve months the share price has lost 70.3%, trading between 0.03 and 0.14.
Tweenvest scores ImmuPharma plc across four factors: quality 37/100, value 75/100. Its strongest factor is value.
IMM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $27.30M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 3.02
- 52-week high
- £0.14
- 52-week low
- £0.03
- Avg volume (3M)
- —
- Shares outstanding
- 625.29M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Quantum BioPharma Ltd.NasdaqCM: QNTM | $27.82M | $3.11 | -9.59% |
| MariMed Inc.OTCPK: MRMD | $27.81M | $0.07 | -10.39% |
| IRLAB Therapeutics AB (publ)OM: IRLAB A | $27.50M | Skr1.86 | -2.32% |
| Neimeth International Pharmaceuticals PlcNGSE: NEIMETH | $27.39M | ₦7.45 | -5.10% |
| Winston Medical Supply Co., Ltd.TPEX: 6817 | $27.26M | NT$47.15 | +5.48% |
| Korean Drug Co., Ltd.KOSDAQ: A014570 | $26.54M | ₩3,275.00 | +2.50% |
| Cessatech A/SNGM: CESSA | $26.25M | Dkr9.30 | +1.75% |
| Earth Science Tech, Inc.OTCPK: ETST | $26.20M | $0.09 | -2.10% |
Figures last refreshed Oct 4, 2026.